Cargando…
Does pamidronate enhance the osteogenesis in mesenchymal stem cells derived from fibrous hamartoma in congenital pseudarthrosis of the tibia?
Neurofibromatosis type 1 (NF1) is a commonly occurring genetic disorder in children. Mutation in the NF1 gene has its implication in poor osteoblastic capabilities. We hypothesised that pamidronate will enhance the osteoblastic potential of the mesenchymal stem cells (MSCs) derived from lipofibromat...
Autores principales: | Madhuri, Vrisha, Mathew, Smitha Elizabeth, Rajagopal, Karthikeyan, Ramesh, Sowmya, Antonisamy, B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440779/ https://www.ncbi.nlm.nih.gov/pubmed/28580399 http://dx.doi.org/10.1016/j.bonr.2016.10.003 |
Ejemplares similares
-
Disturbed Osteoblastic Differentiation of Fibrous Hamartoma Cell from Congenital Pseudarthrosis of the Tibia Associated with Neurofibromatosis Type I
por: Lee, Dong Yeon, et al.
Publicado: (2011) -
Congenital Pseudarthrosis of the Tibia
Publicado: (1935) -
Burnei’s procedure in the treatment of long bone pseudarthrosis in patients having osteogenesis imperfecta or congenital pseudarthrosis of tibia – preliminary report
por: Vlad, C, et al.
Publicado: (2012) -
Congenital Pseudoarthrosis Tibia with Fibrous Hamartoma in a Child with Neurofibromatosis
por: Pujani, Meenu, et al.
Publicado: (2013) -
Trophic effects of multiple administration of mesenchymal stem cells in children with osteogenesis imperfecta
por: Ramesh, Sowmya, et al.
Publicado: (2021)